Evidence map›Paper›PMID 40998784›Full record

ArticleNature communications2025

Metal-free para-selective C-H amination and azidation of N-arylhydroxylamines.

Yaru Bai, Hui-Mei Jiang, Wenbo Xu, Li-Ping Xu, Hongyin Gao

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yaru BaiSchool of Chemistry and Chemical Engineering, Shandong University, 27 South Shanda Road, Ji'nan, 250100, Shandong, China.
Hui-Mei JiangSchool of Chemistry and Chemical Engineering, Shandong University, 27 South Shanda Road, Ji'nan, 250100, Shandong, China.
Wenbo XuSchool of Chemistry and Chemical Engineering, Shandong University, 27 South Shanda Road, Ji'nan, 250100, Shandong, China.
Li-Ping XuSchool of Chemistry and Chemical Engineering, Shandong University, 27 South Shanda Road, Ji'nan, 250100, Shandong, China. xulp@sdu.edu.cn.ORCID http://orcid.org/0000-0002-3967-4921
Hongyin GaoSchool of Chemistry and Chemical Engineering, Shandong University, 27 South Shanda Road, Ji'nan, 250100, Shandong, China. hygao@sdu.edu.cn.ORCID http://orcid.org/0000-0003-4049-6832

Funding

Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2024YQ016Taishan Scholar Foundation of Shandong Province taqn202312066Taishan Scholar Foundation of Shandong Province tsqn202306015
6 · The paper itself

Abstract

Due to the universality of arylamine and arylazide building blocks in pharmaceuticals, natural products and functional materials, the formation of aryl C-N bonds from readily available materials appears to be highly appealing, especially for the exclusive regioselective C-H amination. Despite substantial advancements in the synthesis of aryl C-N bonds, achieving a general, efficient, and para-selective C-H amination under mild conditions remains a significant challenge. Here we showcase a fluorosulfuryl imidazolium triflate-mediated para-selective C-H amination of N-arylhydroxylamines employing primary and secondary amines, diphenylmethanimine and azides as nitrogen source, affording structurally diverse 1,4-diaminoarenes or para-azidoanilides in the absence of oxidants and transition-metal catalysts. This effective protocol exhibits exclusive para-selectivity and good functional group tolerance for both N-arylhydroxylamines and N-nucleophiles (>90 examples). DFT calculations have been performed to elucidate the high chemoselectivity observed amidst multiple nucleophilic and electrophilic species.

Identifiers

PMID40998784
PMCPMC12462474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.